Rochester, NY (August 22, 2019) – Dawnbreaker, Inc. is proud to welcome Dan Keeley who joins the team as a Business Acceleration Manager bringing with him an extensive background in biomedical engineering, innovation and technology commercialization. Most recently, Dan worked for the University of Rochester at UR Ventures and Nextcorps (formerly High Tech Rochester). In both roles Dan helped professors, medical professionals and entrepreneurs develop strategic plans to commercialize their technologies.
Mr. Keeley spent six years at Johnson & Johnson working in new product development and technical project management and has worked on a number of portfolio development projects performing business case analysis and developing a pipeline of products from a single platform technology. Working at Becton Dickinson and Co. Dan helped develop the strategic plan to launch a new segment of their Biosciences division.
“Having worked at a university and in the startup community, I believe strongly in the SBIR and STTR programs’ ability to accelerate innovation. Joining Dawnbreaker, I’m proud to be working for a company that helps make these programs successful,” said Mr. Keeley. “I enjoy the business problem solving that goes into transitioning technologies from the lab to the marketplace and am excited to be able to leverage my expertise in product development, engineering and technology commercialization to help startups and small companies create value from their scientific innovations.”
Throughout his career, Mr. Keeley has worked with a range of biotechnology products including implantable biomaterials, stem cell technologies, high molecular weight growth factors, combination devices and more. He has been awarded 3 patents with 8 patents pending, a publication in the Journal of Neuroscience Methods and was a 2008 Michael J. Fox Foundation Award recipient. Dan has an BS and MEng in Biomedical Engineering from Cornell University’s School of Engineering in addition to an MBA from Cornell’s Johnson School of Management.
